R&D Strategy

Leverage innovative technologies and products as core growth drivers

Asieris Pharmaceuticals has been leveraging innovative technologies and products as core growth drivers. Through its well-established proprietary R&D system, three core technology platforms and expertise in global drug development, the company has been exploring new mechanisms of drug action, efficiently screening and evaluating drug candidates, and committed to launching first-in-class drugs and other innovative medicines with huge unmet medical needs in its areas of focus.